Author: Balcar, Lorenz; Semmler, Georg; Pomej, Katharina; Simbrunner, Benedikt; Bauer, David; Hartl, Lukas; Jachs, Mathias; Paternostro, Rafael; Bucsics, Theresa; Pinter, Matthias; Trauner, Michael; Mandorfer, Mattias; Reiberger, Thomas; Scheiner, Bernhard
Title: Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acuteâ€onâ€chronic liver failure Cord-id: ersapcw7 Document date: 2021_5_28
ID: ersapcw7
Snippet: INTRODUCTION: Recently, based on data from the PREDICT study, the European Foundation for the Study of Chronic Liver Failure (EFâ€CLIF) consortium proposed pathophysiological/prognostic groups in hospitalized patients with cirrhosis: stable decompensated cirrhosis (SDC), unstable decompensated cirrhosis (UDC), preâ€acuteâ€onâ€chronic liver failure (preâ€ACLF), and ACLF. We evaluated the outcomes of these subgroups in a realâ€life cohort of hospitalized patients with cirrhosis. METHODS: Pat
Document: INTRODUCTION: Recently, based on data from the PREDICT study, the European Foundation for the Study of Chronic Liver Failure (EFâ€CLIF) consortium proposed pathophysiological/prognostic groups in hospitalized patients with cirrhosis: stable decompensated cirrhosis (SDC), unstable decompensated cirrhosis (UDC), preâ€acuteâ€onâ€chronic liver failure (preâ€ACLF), and ACLF. We evaluated the outcomes of these subgroups in a realâ€life cohort of hospitalized patients with cirrhosis. METHODS: Patients with cirrhosis developing first AD between 09/2010 and 12/2017 at the Vienna General Hospital were evaluated for this retrospective analysis. RESULTS: Two hundred and ten patients with cirrhosis (aged 57.6 ± 11.8 years) including n = 45 (21.4%) SDC, n = 100 (47.6%) UDC, n = 28 (13.3%) preâ€ACLF, and n = 37 (17.6%) with ACLF were considered. The proposed AD subgroups discriminated between patients with favorable (1â€year mortality: SDC: 6.7% and UDC: 19.6%) and dismal prognosis (90â€day mortality: preâ€ACLF: 42.9%). Interestingly, systemic inflammation gradually increased (e.g., Câ€reactive protein, SDC: 0.9 mg/dl, vs. UDC: 2.0 mg/dl vs. preâ€ACLF: 3.2 mg/dl, p < 0.001) while renal function was progressively deteriorating (creatinine levels, SDC: 0.8 mg/dl vs. UDC: 0.9 mg/dl vs. preâ€ACLF: 1.2 mg/dl, p < 0.001) across prognostic subgroups in patients with cirrhosis. DISCUSSION: The recently proposed pathophysiological/prognostic EFâ€CLIF subgroups are also reproduceable in a realâ€life cohort of cirrhotic patients. As ACLF is a common and important complication, patients at risk of preâ€ACLF at index AD should be evaluated and if disease proceeds, been treated early and aggressively to avoid excessive mortality.
Search related documents:
Co phrase search for related documents- aclf decompensated cirrhosis and acute decompensation: 1, 2, 3
- aclf define and acute decompensation: 1
- aclf development and acute decompensation: 1, 2
- aclf grade and acute decompensation: 1
- aclf patient and acute decompensation: 1
- aclf specific and acute decompensation: 1, 2
Co phrase search for related documents, hyperlinks ordered by date